Shilpa Medicare Ltd's earnings have declined by -4.7%, whereas share price has appreciated 1.1% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.
Shilpa Medicare Ltd share price has appreciated 22.8% annually (CAGR) over the past ten years.
Past 10 years financial track record analysis and assessment of future prospects by Moneyworks4me indicates that Shilpa Medicare Ltd is a good long term investment. However, you need to ensure you buy at a right price to earn good returns.
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
The company has earned its spurs as a successful and reliable partner
The company has earned its spurs as a successful and reliable partner within the pharmaceutical industry. Buyers within the country and from across the borders count on its fast track integrated process development and finely honed expertise of its skilled and experienced personnel. The company is already exporting to USA, Canada, Australia, Japan and European countries viz., Germany, Switzerland, Netherlands, Belgium, Spain, Greece, Cyprus, Italy, United Kingdom etc., South American countries like Mexico, Brazil, Columbia etc, African countries like Kenya, Nigeria and West Indies etc, Asian countries like Singapore, Taiwan, China, Malaysia, Thailand and closer to home to Iran, Egypt, Pakistan and Bangladesh. Shilpa Medicare is synergizing strength through tie-ups for manufacturing products and co-marketing rights, for it believes in working together and sharing success.
Being proactive in approach, the company continually seeks out enquiryâ€™s for development of new products drawing from the extensive knowledge-base of its qualified and experienced people as well as sophisticated facilities.
Product range of the company includes:
PRODUCTS UNDER DEVELOPMENT (Oncology)
Awards & Achievements:
Raymond Moses– Founder MoneyWorks4me, guides you on how Mindset and System together form a complete solution that ensures you invest successfully in stocks, mutual funds and reach your goals…safely
Your portfolio may have substantial downside risks!
Review your portfolio with MoneyWorks4me and get it future ready. Let us not miss our hard earned gains. Book your Free demo to discuss with our Experts.